Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis

被引:212
|
作者
Gaia, Silvia [1 ]
Carenzi, Silvia [1 ]
Barilli, Angela L. [1 ]
Bugianesi, Elisabetta [1 ]
Smedile, Antonina [1 ]
Brunello, Franco [1 ]
Marzano, Alfredo [1 ]
Rizzetto, Mario [1 ]
机构
[1] San Giovanni Battista Hosp, I-10128 Turin, Italy
关键词
Transient elastography; Fibroscan; Liver fibrosis; Viral hepatitis; NAFLD; NONINVASIVE ASSESSMENT; STIFFNESS MEASUREMENT; SAMPLING VARIABILITY; DIAGNOSIS; BIOPSY; STEATOSIS; CIRRHOSIS; VALUES; PROGRESSION; MARKER;
D O I
10.1016/j.jhep.2010.06.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Transient elastography (TE) is validated in chronic hepatitis C (CHC) to evaluate hepatic fibrosis: however, limited data are available in chronic hepatitis B (CUB) and Non-Alcoholic Fatty Liver Disease (NAFLD). This prospective study is aimed to assess the accuracy and the efficacy of TE for the detection of fibrosis in patients with chronic liver disease of different etiology and to evaluate the effect of steatosis on the liver stiffness measurement (LSM). Methods: TE was performed in 219 consecutive patients with chronic liver disease (35% CHC, 32% CHB, and 33% NAFLD) within 6 months of the liver biopsy. Results: LSM was related to the fibrosis stage in each group (CHC: p = 0.596, p<0.001: CUB: p = 0.418, p<0.001: NAFLD: p = 0.573, p<0.001), but the correlation was less strong in CHB and NAFLD than in CHC patients. In CHB patients with histological cirrhosis (F4), the median stiffness value was almost two times lower than in patients with severe fibrosis (F3). In NAFLD patients with advanced fibrosis (F3) and severe steatosis (>33%), the LSM values were lower than expected and were similar to those of patients with initial fibrosis (F1) and fat <33%. TE underestimated the stage of fibrosis in 75% of patients with F3 and steatosis >33%. At multiple logistic regression analysis, in CHC and CHB patients, LSM was the only predictive variable of severe fibrosis/cirrhosis (OR = 1.42, p = 0.003 and OR = 1.354, p = 0.003, respectively), while in NAFLD subjects BMI and AST (OR = 1.433, p = 0.002 and OR = 1.053, p = 0.020, respectively) but not LSM were independently related with advanced fibrosis and cirrhosis. Conclusions: This study confirms that TE can be considered a valid support to detect fibrosis in chronic liver disease related to HCV but it should be interpreted cautiously in CHB and NAFLD patients, where host or disease-related factors may modify its accuracy. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [1] Transient elastography, liver fibrosis, body mass index, non-alcoholic fatty liver disease, and chronic viral hepatitis
    Haqqi, S. A.
    Siddiqui, A. R.
    Khatri, A.
    Farrukh, S. Z.
    Kalwar, M. A.
    Matin, B.
    Niaz, S. K.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 365 - 365
  • [2] Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    Chan, Henry Lik-Yuen
    [J]. JOURNAL OF HEPATOLOGY, 2011, 55 (02) : 497 - 497
  • [3] Reply to: "Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?"
    Gaia, Silvia
    [J]. JOURNAL OF HEPATOLOGY, 2011, 55 (02) : 498 - 498
  • [4] Transient elastography in non-alcoholic fatty liver disease
    Abenavoli, Ludovico
    Beaugrand, Michel
    [J]. ANNALS OF HEPATOLOGY, 2012, 11 (02) : 172 - 178
  • [5] Liver fibrosis by transient elastography in HIV patients with non-alcoholic fatty liver disease (NAFLD)
    Schiavini, M.
    Meraviglia, P.
    Minisci, D.
    Ortu, M.
    Carenzi, L.
    Pocaterra, D.
    Ricci, E.
    Bonfanti, P.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (07) : A59 - A59
  • [6] Transient elastography for monitoring the fibrosis of non-alcoholic fatty liver disease for 4 years
    Suzuki, Kaori
    Yoneda, Masato
    Imajo, Kento
    Kirikoshi, Hiroyuki
    Nakajima, Atsushi
    Maeda, Shin
    Saito, Satoru
    [J]. HEPATOLOGY RESEARCH, 2013, 43 (09) : 979 - 983
  • [7] Comparison of transient elastography and NAFLD fibrosis score in non-alcoholic fatty liver disease
    Wu, Y.
    Weltman, M.
    Eslick, G. D.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 100 - 100
  • [8] Comparing the performance of Fibrosis-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score with transient elastography scores of people with non-alcoholic fatty liver disease
    Cox, Ben
    Trasolini, Roberto
    Gaits, Ciaran
    Yoshida, Eric M.
    Marquez, Vladimir
    [J]. CANADIAN LIVER JOURNAL, 2021, 4 (03): : 275 - 282
  • [9] Liver enzymes and fibrosis markers in patients with non-alcoholic fatty liver disease and concomitant chronic viral hepatitis
    Van Iderstine, Micah Grubert
    Uhanova, J.
    Minuk, Gerald Y.
    [J]. CANADIAN LIVER JOURNAL, 2021, 4 (03): : 317 - 321
  • [10] Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B
    Sharif, Asim
    Abbas, Zaigham
    Ahmed, Samiuddin
    Samjo, Shoukat Ali
    Baqai, Khurram
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (10)